NYSE · MTD · Diagnostics & Research
Mettler-Toledo International, I (MTD) stock analysis
- MTD gained 12.6% over the past month versus 0.0% for the S&P 500, ranking 32nd of 497 S&P 500 stocks.
- Over 12 months it returned +23.6%, 7.8 points ahead of the S&P 500, and trades 0.0% below its 52-week high.
- In the last 30 days 2 analysts raised earnings estimates and 0 cut; forward EPS moved +0.1% (+1.0% over 90 days).
- It sits in the Laboratory & analytical tools segment of the Medtech, Diagnostics & Care, where the 1-month median return is +6.4%.
- The daily chart reads Intermediate uptrend · Breakout retest (since Oct 19, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 19, 2026
- Close above EMA20 above EMA50
- EMA50 rose over the last ten sessions
- Confirmed swing highs and lows are rising
50 occurrences in 10 years. The median move over the next 20 sessions was +1.4%, positive 52% of the time, against +1.4% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
13 analysts cover the stock
Where it sits in the supply chain
Medtech, Diagnostics & Care · Tools & research
Instruments and reagents serve research and labs; budgets and inventories affect orders.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.